The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of Fuhrman grading system for Japanese patients with renal cell carcinoma.
Yoshiyuki Miyaji
No relevant relationships to disclose
Naoki Kanomata
No relevant relationships to disclose
Shin Ohira
No relevant relationships to disclose
Aya Ohbatake
No relevant relationships to disclose
Masaichiro Fujita
No relevant relationships to disclose
Kazuhiko Fukumoto
No relevant relationships to disclose
Tomohiro Fujii
No relevant relationships to disclose
Yoshimasa Jo
No relevant relationships to disclose
Teruhiko Yokoyama
No relevant relationships to disclose
Atsushi Nagai
No relevant relationships to disclose